At Butterfly Therapeutics, we uphold values such as innovation, scientific consciousness, ambition, progressivism, empathy, and pragmatism.
Our team consists of individuals from diverse backgrounds with different and complementary skills who work together to meet the needs of patients and healthcare providers.
We go above and beyond to innovate. Our decisions and actions are guided by a rigorous ethical and scientific approach, ensuring optimal adaptation of our digital therapy solutions to healthcare practices and their benefits for patients.
Each member of our team is determined to improve pain management, tackling challenges with perseverance, creativity, and resilience.
After starting her career in developing access to culture, Mélanie Péron ventured into entrepreneurship in 2011 and founded « l’Effet Papillon », now known as « Butterfly Therapeutics ».
A personal experience with a hospitalized patient close to her provided the energy to conduct over 10 years of research, resulting in the creation of Bliss DTx, a digital sedation solution.
In September 2021, in recognition of her commitment to the healthcare field, she was awarded the Knight of the National Order of Merit by Professor Norbert Ifrah, President of the National Cancer Institute.
With over 20 years of experience in business and consulting in the fields of Health and Technology, Etienne joined Melanie in the venture in 2020.
A graduate of Arts and Métiers ParisTech, he has worked in renowned companies such as L’Oréal, Bossard Gemini Consulting, and PwC.
Before Butterfly Therapeutics, Etienne led a team of over 100 experts and consultants in the areas of health product evaluation and market access for IQVIA France (a global leader in health-related data and services).